PMC:7105881 / 40080-40249
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T227 | 60-64 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T520 | 152-154 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
T521 | 152-154 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T252 | 114-123 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T253 | 152-154 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32265848-16919855-36511169 | 146-150 | 16919855 | denotes | 2007 |
32265848-23573979-36511170 | 163-167 | 23573979 | denotes | 2013 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T229 | 0-169 | Sentence | denotes | Other factors that potentially affect the immunogenicity of SARS subunit vaccines include immunization routes and adjuvants (Zakhartchouk et al., 2007; Li et al., 2013). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T717 | 42-56 | BV_15 | denotes | immunogenicity |
T718 | 60-64 | SP_10 | denotes | SARS |
T719 | 114-123 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
T57205 | 42-56 | BV_15 | denotes | immunogenicity |
T14723 | 60-64 | SP_10 | denotes | SARS |
T90462 | 114-123 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |